PMC:7396557 / 85077-85364 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T889","span":{"begin":111,"end":116},"obj":"PR:000000134"},{"id":"T890","span":{"begin":118,"end":122},"obj":"PR:000001393"},{"id":"T891","span":{"begin":128,"end":132},"obj":"PR:000001395"},{"id":"T892","span":{"begin":202,"end":224},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T95323","span":{"begin":111,"end":116},"obj":"PR:000000134"},{"id":"T81429","span":{"begin":118,"end":122},"obj":"PR:000001393"},{"id":"T37285","span":{"begin":128,"end":132},"obj":"PR:000001395"},{"id":"T7919","span":{"begin":202,"end":224},"obj":"CHEBI:67079;CHEBI:67079"}],"text":"Among 89 elderly patients with severe pneumonia, the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI effectively reduced inflammatory mediators, thus, playing an active therapeutic effect (Lv et al., 2017)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T517","span":{"begin":38,"end":47},"obj":"Disease"}],"attributes":[{"id":"A517","pred":"mondo_id","subj":"T517","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"Among 89 elderly patients with severe pneumonia, the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI effectively reduced inflammatory mediators, thus, playing an active therapeutic effect (Lv et al., 2017)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T811","span":{"begin":128,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0053704"},{"id":"T812","span":{"begin":243,"end":249},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Among 89 elderly patients with severe pneumonia, the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI effectively reduced inflammatory mediators, thus, playing an active therapeutic effect (Lv et al., 2017)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T68753","span":{"begin":67,"end":72},"obj":"Chemical"},{"id":"T300","span":{"begin":118,"end":120},"obj":"Chemical"},{"id":"T84714","span":{"begin":128,"end":130},"obj":"Chemical"}],"attributes":[{"id":"A73151","pred":"chebi_id","subj":"T68753","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A54806","pred":"chebi_id","subj":"T300","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A74488","pred":"chebi_id","subj":"T300","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A83798","pred":"chebi_id","subj":"T84714","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A902","pred":"chebi_id","subj":"T84714","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Among 89 elderly patients with severe pneumonia, the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI effectively reduced inflammatory mediators, thus, playing an active therapeutic effect (Lv et al., 2017)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T634","span":{"begin":0,"end":287},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Among 89 elderly patients with severe pneumonia, the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI effectively reduced inflammatory mediators, thus, playing an active therapeutic effect (Lv et al., 2017)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T344","span":{"begin":38,"end":47},"obj":"Phenotype"}],"attributes":[{"id":"A344","pred":"hp_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Among 89 elderly patients with severe pneumonia, the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI effectively reduced inflammatory mediators, thus, playing an active therapeutic effect (Lv et al., 2017)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2423","span":{"begin":111,"end":116},"obj":"Gene"},{"id":"2424","span":{"begin":118,"end":122},"obj":"Gene"},{"id":"2425","span":{"begin":128,"end":132},"obj":"Gene"},{"id":"2437","span":{"begin":17,"end":25},"obj":"Species"},{"id":"2451","span":{"begin":38,"end":47},"obj":"Disease"}],"attributes":[{"id":"A2423","pred":"tao:has_database_id","subj":"2423","obj":"Gene:7124"},{"id":"A2424","pred":"tao:has_database_id","subj":"2424","obj":"Gene:3569"},{"id":"A2425","pred":"tao:has_database_id","subj":"2425","obj":"Gene:3576"},{"id":"A2437","pred":"tao:has_database_id","subj":"2437","obj":"Tax:9606"},{"id":"A2451","pred":"tao:has_database_id","subj":"2451","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Among 89 elderly patients with severe pneumonia, the SFI treatment group had significantly decreased levels of TNF-α, IL-6, and IL-8 7 days after administration, indicating that SFI effectively reduced inflammatory mediators, thus, playing an active therapeutic effect (Lv et al., 2017)."}